ICD-10 Code D47.4 | Osteomyelofibrosis Symptoms, Diagnosis, Billing

Osteomyelofibrosis is a rare hematological disorder characterized by the replacement of normal bone marrow with fibrous tissue, leading to hematopoietic dysfunction. This condition can result from various underlying diseases, including myeloproliferative neoplasms. Accurate coding with ICD-10 Code D47.4 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat affected patients.

What is ICD-10 Code D47.4 for Osteomyelofibrosis?

ICD-10 Code D47.4 represents Osteomyelofibrosis, a condition where the bone marrow is replaced by fibrous tissue, impairing blood cell production. This code should be used when documenting cases of osteomyelofibrosis, particularly in patients with underlying myeloproliferative disorders. Proper use of this code facilitates accurate clinical documentation and appropriate billing for healthcare services rendered.

ICD-10 Code D47.4 – Clinical Definition and Explanation of Osteomyelofibrosis

Osteomyelofibrosis is primarily caused by myeloproliferative disorders, leading to progressive bone marrow fibrosis and hematological abnormalities. The condition necessitates medical attention due to its potential complications, including anemia, leukopenia, and thrombocytopenia. Early diagnosis and management are crucial for improving patient outcomes.

Key Clinical Features:

• Bone marrow biopsy shows increased fibrosis and decreased hematopoietic cells.
• Symptoms may include fatigue, weakness, and splenomegaly.
• Associated with myeloproliferative neoplasms such as polycythemia vera.
• Can lead to complications like anemia and increased risk of infections.

ICD-10 Code D47.4 for Osteomyelofibrosis – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code D47.4 is utilized to document the patient's symptoms, assessment findings, and treatment plans related to osteomyelofibrosis. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition and facilitating appropriate management strategies.

What Does ICD-10 Code D47.4 for Osteomyelofibrosis Mean in SOAP Notes?

ICD-10 Code D47.4 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of osteomyelofibrosis. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting electronic health record documentation standards.

Treatment Options for ICD-10 Code D47.4 – Osteomyelofibrosis

Osteomyelofibrosis may require hospitalization for management of complications and supportive care. Treatment focuses on addressing the underlying cause and alleviating symptoms.

Antibiotic Therapy:

• Not applicable as osteomyelofibrosis is not an infectious condition.

Supportive Care:

• Transfusions for anemia management.
• Erythropoiesis-stimulating agents as needed.
• Monitoring for complications such as infections.

Infection Control:

• Standard precautions to prevent infections in immunocompromised patients.

How to Document Symptoms of Osteomyelofibrosis (ICD-10 D47.4) in SOAP Notes

Subjective:

• Patient reports fatigue and weakness.
• History of splenomegaly noted.
• Complaints of frequent infections.
• No recent travel or exposure to infectious diseases.

Objective:

• Bone marrow biopsy shows increased fibrosis.
• CBC reveals anemia and thrombocytopenia.
• Physical exam shows splenomegaly.
• Vital signs stable with no fever.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Osteomyelofibrosis (ICD-10 Code D47.4)

Assessment:

• Diagnosis: Osteomyelofibrosis, moderate severity.
• ICD-10 Code: D47.4.
• Contributing factors: Myeloproliferative disorder.
• Monitor for complications such as anemia and infections.

Plan:

• Administer blood transfusions as needed.
• Consider erythropoiesis-stimulating agents.
• Educate patient on signs of infection.
• Schedule follow-up in 4 weeks for reassessment.

Treatment & Plan Section for ICD-10 Code D47.4 – Osteomyelofibrosis

• Transfusion therapy for symptomatic anemia.
• Erythropoiesis-stimulating agents to improve hemoglobin levels.
• Regular monitoring of blood counts and symptoms.
• Patient education on infection prevention and management.

Using ICD-10 Code D47.4 for Osteomyelofibrosis in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings.
• Use D47.4 in conjunction with relevant laboratory and imaging codes.
• Align treatment plans with clinical guidelines for justified billing.
• Document all patient interactions and treatment decisions clearly.

Related ICD-10 Codes Often Used with Osteomyelofibrosis

• D47.1 – Myelofibrosis
• D47.3 – Polycythemia vera
• D47.2 – Essential thrombocythemia
• D46.9 – Myelodysplastic syndrome, unspecified

ICD-10 Code D47.4 in Medical Billing and Insurance for Osteomyelofibrosis

ICD-10 Code D47.4 is crucial for billing in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services provided.

Billing Notes:

• Document all relevant clinical findings and treatment plans.
• Use D47.4 in conjunction with other applicable codes for comprehensive billing.
• Ensure that the medical necessity for services is clearly established in documentation.
• Review payer-specific guidelines for coding and billing compliance.

Common CPT Pairings: